The National Centre for Pharmacoeconomics (NCPE) in Ireland are undertaking an assessment of Lutathera for approval in Ireland which is the first step to getting PRRT (Peptide receptor radionuclide therapy) here in Ireland.
[more information on PRRT below]
This is very important for Irish NET Patients, as having PRRT available in Ireland would mean Patients do not have to travel to another country to get it.
This survey was part of the NET Patient Day events on Saturday, but we want everyone included, so here is the link for anyone that has not already done the survey.
I made it so that it takes under 2 minutes to complete, so I hope you can please take the time to do it.